Hypotension in Transgenic Mice Overexpressing Human Bradykinin B2Receptor
Authors:
- 1 January 1997
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 29 (1) , 488-493
Abstract
Bradykinin binds to its receptor at target organs and exerts a wide spectrum of biological activities including vasodilation, smooth muscle contraction and relaxation, pain, and inflammation. To gain a better insight into the physiological function of this potent vasoactive peptide, we created transgenic mice that harbor the human bradykinin B2receptor transgene under the control of the Rous sarcoma virus 3′-LTR promoter (RSV-cHBKR). Expression of HBKR in these transgenic mice was identified in the aorta, brain, heart, lung, liver, kidney, uterus, and prostate gland by reverse transcription-polymerase chain reaction Southern blot analysis. Two transgenic mouse lines expressing the human B2receptor resulted in a significant reduction of blood pressure (84.2±0.6 mm Hg, n=28; 76.9±0.8 mm Hg, n=24;P<.001) compared with the control littermates (96.9±0.4 mm Hg, n=52). Administration of Hoe 140, a bradykinin B2receptor antagonist, restored the blood pressure of the transgenic mice to normal levels within 1 hour, and the effect diminished within 4 hours. The transgenic mice displayed enhanced blood pressure-lowering effect induced by a bolus intra-aortic injection of kinin and showed increased response in kinin-induced uterine smooth muscle contractility compared with control littermates. These studies show that overexpression of human bradykinin B2receptor causes a sustained reduction of blood pressure in transgenic mice. They also suggest that the B2receptor-mediated signal transduction pathway plays a role in blood pressure regulation.Keywords
This publication has 27 references indexed in Scilit:
- The Human Bradykinin B2 Receptor Gene: Full-Length cDNA, Genomic Organization and Identification of the Regulatory RegionBiochemical and Biophysical Research Communications, 1995
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995
- Structure and Chromosomal Localization of the Gene (BDKRB2) Encoding Human Bradykinin B2 ReceptorGenomics, 1994
- Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic ReceptorScience, 1994
- Human tissue kallikrein induces hypotension in transgenic mice.Hypertension, 1994
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Bradykinin receptors: Pharmacological properties and biological rolesPharmacology & Therapeutics, 1992
- Cosegregation of blood pressure with a kallikrein gene family polymorphism.Hypertension, 1991
- Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probesJournal Of Hypertension, 1989
- Computer-assisted analysis of complex concentration-response dataJournal of Pharmacological Methods, 1985